Now showing items 1-6 of 6
Cancer Immunotherapy with CAR-T cells for Hematological Malignancies
(Scientific & Academic Publishing, 2017-04)
Cancer treatment for hematological malignancies traditionally included systemic chemotherapy and localized radiotherapy for central nervous system (CNS) disease. These therapies in addition to their adverse effects’ profile ...
Screening for raised base-line values of serum CRP as an independent risk factor for cardiovascular diseases among adults in Bethlehem District using hs-CRP assay
(Pluto Journals, 2011)
C-reactive protein is a non-specific indicator of inflammation. The CRP test is useful in evaluating patients with an acute myocardial infarction (AMI). The level of CRP correlates with peak levels of the CK-MB isoenzyme, ...
Screening for Vancomycin-Resistant and Intermediate S. aureus (VRSA & VISA) by the E-test in the hospitals of Bethlehem and Jerusalem Districts
(Bethlehem University Journal, 2011)
The glycopeptide antibiotic vancomycin is frequently used as the drug of choice for the treatment of infections caused by methicillin-resistant Staphylococcus aureus (MRSA). MRSA has been reported to cause severe life ...
The frequency of the blood group antigen K in Hebron District
(Pluto Journals, 2013)
The Kell blood group system is an interesting mix of high-frequency and low-frequency antigens. It consists of 25 antigens, which include six pairs or triplets of antithetical antigens. All of these polymorphisms represent ...
Screening for ICA Autoantibodies among Healthy Young Adults from Bethlehem District: A Pilot Study
(International journal of diabetes research, Scientific & Academic Publishing, 2019-02)
Diabetes mellitus (DM) is a common disorder in the Palestinian population. It causes economic burden on the society due to costs of management of the disease. Therefore, being able to predict the development of type 1 DM ...
Immune Checkpoint Blockade Therapy for Cancer
(International Journal of Tumor Therapy, 2019-03)
The expression of immune checkpoint molecules such as programmed cell death ligand 1 (PD-L1) on the surface of cancer cells and programmed cell death 1 (PD-1) and cytotoxic T-lymphocyte associated protein 4 (CTLA-4) on the ...